Your browser doesn't support javascript.
loading
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
Mc Laughlin, Anna M; Schmulenson, Eduard; Teplytska, Olga; Zimmermann, Sebastian; Opitz, Patrick; Groenland, Stefanie L; Huitema, Alwin D R; Steeghs, Neeltje; Müller, Lothar; Fuxius, Stefan; Illerhaus, Gerald; Joerger, Markus; Mayer, Frank; Fuhr, Uwe; Holdenrieder, Stefan; Hempel, Georg; Scherf-Clavel, Oliver; Jaehde, Ulrich; Kloft, Charlotte.
Afiliação
  • Mc Laughlin AM; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, 12169 Berlin, Germany.
  • Schmulenson E; Graduate Research Training Program PharMetrX, 12169 Berlin, Germany.
  • Teplytska O; Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, 53121 Bonn, Germany.
  • Zimmermann S; Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, 53121 Bonn, Germany.
  • Opitz P; Institute of Pharmacy and Food Chemistry, Julius-Maximilians-Universität Würzburg, 97074 Würzburg, Germany.
  • Groenland SL; Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, 48149 Muenster, Germany.
  • Huitema ADR; The Netherlands Cancer Institute, Department of Clinical Pharmacology, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands.
  • Steeghs N; The Netherlands Cancer Institute, Department of Pharmacy & Pharmacology, 1066 CX Amsterdam, The Netherlands.
  • Müller L; Department of Clinical Pharmacy, University Medical Center, Utrecht University, 3584 CX Utrecht, The Netherlands.
  • Fuxius S; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, 3584 CX Utrecht, The Netherlands.
  • Illerhaus G; The Netherlands Cancer Institute, Department of Clinical Pharmacology, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands.
  • Joerger M; Onkologie UnterEms, 26789 Leer, Germany.
  • Mayer F; Onkologische Schwerpunktpraxis Heidelberg, 69115 Heidelberg, Germany.
  • Fuhr U; Klinik für Hämatologie, Onkologie, und Palliativmedizin, Klinikum Stuttgart, 70174 Stuttgart, Germany.
  • Holdenrieder S; Cantonal Hospital St. Gallen, Department of Medical Oncology & Hematology, CH-9000 St. Gallen, Switzerland.
  • Hempel G; Praxis und Tagesklinik, Prof. Dr. Helmut Oettle und Prof. Dr. Dr. Frank Mayer, 88045 Friedrichshafen, Germany.
  • Scherf-Clavel O; Department I of Pharmacology, Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, University of Cologne, 50923 Cologne, Germany.
  • Jaehde U; German Heart Center Munich, Technical University Munich, Institute of Laboratory Medicine, 80636 Munich, Germany.
  • Kloft C; Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, 48149 Muenster, Germany.
  • For The On-Target Study Consortium; Institute of Pharmacy and Food Chemistry, Julius-Maximilians-Universität Würzburg, 97074 Würzburg, Germany.
Cancers (Basel) ; 13(24)2021 Dec 14.
Article em En | MEDLINE | ID: mdl-34944899
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha